<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315013</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>1688611</PubmedId>
            <Abstract>Epstein-Barr virus (EBV)-specific CTL clones were isolated that recognized A-type EBV transformants but not B-type transformants. These A-type-specific CTL clones (HLA B8 restricted) were used to screen peptides derived from the EBV nuclear antigens (EBNAs) 2, 3, 4, and 6 as potential CTL epitopes. Of the 76 peptides screened, one sequence from EBNA 3 (residues 329-353) was recognized by A-type-specific CTL clones after absorption onto target cells (either autologous B-type transformants or PHA blasts). This report is the first description of an EBV target epitope recognized by specific CTL clones.</Abstract>
            <ArticleYear>1990</ArticleYear>
            <ArticlePages>345-9</ArticlePages>
            <ArticleTitle>An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Burrows</LastName>
                    <ForeName>S R</ForeName>
                </Author>
                <Author>
                    <LastName>Sculley</LastName>
                    <ForeName>T B</ForeName>
                </Author>
                <Author>
                    <LastName>Misko</LastName>
                    <ForeName>I S</ForeName>
                </Author>
                <Author>
                    <LastName>Schmidt</LastName>
                    <ForeName>C</ForeName>
                </Author>
                <Author>
                    <LastName>Moss</LastName>
                    <ForeName>D J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Queensland Institute of Medical Research, Herston, Brisbane, Australia.</Affiliations>
            <ArticleChemicalList>Antigens, Viral;Epitopes;Epstein-Barr Virus Nuclear Antigens;Peptides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antigens, Viral(immunology); B-Lymphocytes(immunology); Cell Line; Cell Nucleus(immunology); Cell Transformation, Viral; Epitopes(analysis); Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human(immunology); Humans; Lymphocyte Activation; Molecular Sequence Data; Peptides(chemical synthesis); T-Lymphocytes, Cytotoxic(immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/)</Comments>
            <Journal>
                <Volume>171</Volume>
                <Issue>1</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>EBNA 3 (334-353)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AWNAGFLRGRAYGIDLLRTE</LinearSequence>
                        <StartingPosition>320</StartingPosition>
                        <EndingPosition>339</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8AZJ8</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10376</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text page 346</LocationOfData>
                <EpitopeId>5678</EpitopeId>
                <ReferenceStartingPosition>334</ReferenceStartingPosition>
                <ReferenceEndingPosition>353</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>1375294</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Human herpesvirus 4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>The T cell clone, which recognized autologous A-type EBV transformants but failed to recognize autologous B-type transformants, was generated from an EBV seropositive donor.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>301</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Mismatched MHC molecules</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Human herpesvirus 4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10376</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>315057</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10376</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Human herpesvirus 4 (Epstein-Barr virus)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>The T cell clone, which recognized autologous A-type EBV transformants but failed to recognize autologous B-type transformants, was generated from an EBV seropositive donor.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>301</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Mismatched MHC molecules</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>EBNA 3 (334-348)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AWNAGFLRGRAYGID</LinearSequence>
                                        <StartingPosition>320</StartingPosition>
                                        <EndingPosition>334</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8AZJ8</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10376</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was mapped to the region of EBNA 3 between amino acids 334-353 using overlapping 15mers spanning residues 329-353. Only peptides spanning residues 334-348 and 339-353 were reactive.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

